Immediate Impact
8 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
2024 Standout
Works of F. Rivera Herrero being referenced
CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
2018
Importance of tumour symptoms and extent of disease on efficacy of first-line FOLFOX4 ± panitumumab (pmab) in patients (pts) with RAS wild-type (WT)/BRAF WT metastatic colorectal cancer (mCRC) in the PRIME study
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| F. Rivera Herrero | 58 | 17 | 18 | 19 | 68 | |
| Gabriel Raab | 41 | 19 | 28 | 14 | 85 | |
| Laura Mazzeo | 57 | 25 | 12 | 19 | 105 | |
| Fabio Gelsomino | 65 | 10 | 21 | 19 | 93 | |
| M. Bailón-Cuadrado | 55 | 10 | 49 | 25 | 112 | |
| Daniel D’Almeida Preto | 39 | 15 | 19 | 21 | 79 | |
| Emilio Fonseca‐Sánchez | 40 | 23 | 17 | 15 | 90 | |
| Béla Pikó | 56 | 19 | 7 | 20 | 84 | |
| Muhammad O. Awiwi | 42 | 35 | 24 | 19 | 96 | |
| Ismael Macías | 61 | 29 | 42 | 23 | 91 | |
| Angela Stefania Ribecco | 57 | 25 | 11 | 13 | 87 |
All Works
Loading papers...